Weekend lie-in 'CUTS childhood obesity by 30 per cent' Daily Mail Fri, 20 Apr 2012 09:47 AM PDT If your children are still lazing in bed while you are reading this, it may be an idea to leave them where they are, says scientists from Hallym University Sacred Heart Hospital in Seoul, South Korea. | Have Your Say BruDirect.com Fri, 20 Apr 2012 09:43 AM PDT Older adults who get thorough dental cleanings may be somewhat less likely to have a heart attack or stroke than their peers who are less careful about oral hygiene, a new study suggests. | Great Ape Heart Project: Zoo Atlanta's Satu The Orangutan Sits For Ultrasound The Huffington Post Fri, 20 Apr 2012 09:08 AM PDT ATLANTA (AP) â" The 9-year-old patient sits still, munching on popcorn and sipping grape juice while he gets an ultrasound of his heart. Every so often, he wiggles free long enough to swing from the ceiling or stick out his tongue before resuming a statue-like pose. | New Zealand woman's 2-gallon-a-day Coca-Cola habit cited in death New York Post Fri, 20 Apr 2012 08:48 AM PDT WELLINGTON, New Zealand â" Experts say a New Zealand woman's 2-gallon-a-day Coca-Cola habit probably contributed to her death, a conclusion that led the soft-drink giant to note that even water can be deadly in excessive amounts. Natasha Harris, a 30-year-old, stay-at-home mother of eight from Invercargill, died of a heart... | Five-month-old waiting for new heart Duke University Fri, 20 Apr 2012 08:20 AM PDT Published: Thursday, April 19, 2012 at 10:15 a.m. Five-month-old Hannah Dombrowski of Wilmington needs a new heart, and she needs it fast. Hannah is one of three children younger than a year old on the waiting list for a heart transplant in North Carolina. | Audrey will need less stress - Nicholls RTE News Fri, 20 Apr 2012 08:20 AM PDT Coronation Street star Sue Nicholls has said that her character Audrey Roberts may pursue an easier life after she suffers a heart attack. | New warnings on Novartis MS pill in Europe and U.S Reuters via Yahoo! Canada News Fri, 20 Apr 2012 08:02 AM PDT LONDON (Reuters) - European and U.S. regulators have backed the continued use of Novartis AG's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said on Friday the drug needed to carry stronger warnings on heart risks. Novartis said the decision meant the drug remained on-track to be a "blockbuster" - one with annual sales above $1 billion. Prospects for Gilenya ... | | |
|